Acitretin for the treatment of psoriasis: An assessment of national trends

Journal of Drugs in Dermatology

Volumn 10, Issue 8, 2011, Pages 873-877

  Ghasri, Pedram ^a   Yentzer, Brad A ^a   Dabade, Tushar S ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE DIPROPIONATE; CALCIPOTRIOL; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYCLOSPORIN; EFALIZUMAB; ETANERCEPT; ETRETIN; FLUOCINOLONE ACETONIDE; FLUOCINONIDE; FLUTICASONE PROPIONATE; METHOTREXATE; MOMETASONE FUROATE; TAZAROTENE; TRIAMCINOLONE ACETONIDE; ULOBETASOL PROPIONATE;

ADULT; ARTICLE; CAUCASIAN; CORTICOSTEROID THERAPY; DRUG DOSE REGIMEN; DRUG MECHANISM; FEMALE; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; PHOTOTHERAPY; PHYSICIAN; PRESCRIPTION; PSORIASIS;

ACITRETIN; ADMINISTRATION, TOPICAL; COMBINED MODALITY THERAPY; DATABASES, FACTUAL; DERMATOLOGIC AGENTS; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; HUMANS; KERATOLYTIC AGENTS; MALE; PSORIASIS; RETINOIDS; UNITED STATES;

EID: 80053067067     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Krueger JG, Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis 2005;64 Suppl 2:ii30-ii36. (Pubitemid 40288517)
2. Menter A, Korman NJ, Elmets CA et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol 2009;61:451-85.
3. Warren RB, Griffiths CE. Systemic therapies for psoriasis: methotrexate, retinoids, and cyclosporine. Clin Dermatol 2008;26:438-47.
4. Tong PS, Horowitz NN, Wheeler LA. Trans retinoic acid enhances the growth response of epidermal keratinocytes to epidermal growth factor and transforming growth factor beta. J Invest Dermatol 1990;94:126-31. (Pubitemid 20046052)
5. Ormerod AD, Campalani E, Goodfield MJ. British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology. Br J Dermatol 2010;162:952-63.
6. Hu J, Balkrishnan R, Camacho F et al. The frequent use of oral retinoids in combination with other treatments for psoriasis: a retrospective analysis. J Cutan Med Surg 2004;8:411-4. (Pubitemid 41414109)
7. Ashcroft DM, Li Wan PA, Williams HC et al. Combination regimens of topical calcipotriene in chronic plaque psoriasis: systematic review of efficacy and tolerability. Arch Dermatol 2000;136:1536-43. (Pubitemid 32009275)
8. Polano MK, Van der Rhee HJ, Van der Schroeff JG. A three-year follow-up study of psoriasis patients treated with low dosages of etretinate orally and corticosteroids topically. Acta Derm Venereol 1982;62:361-4.
9. Stiefel Laboratories I. Soriatane Package Insert. http://www.soriatane. com/media/pi.pdf. 2010. Ref Type: Electronic Citation
10. Lowenthal KE, Horn PJ, Kalb RE. Concurrent use of methotrexate and acitretin revisited. J Dermatolog Treat 2008;19:22-6. (Pubitemid 351252717)
11. Rosenbaum MM, Roenigk HH, Jr. Treatment of generalized pustular psoriasis with etretinate (Ro 10-9359) and methotrexate. J Am Acad Dermatol 1984;10:357-61. (Pubitemid 14181965)
12. Ormerod AD, Campalani E, Goodfield MJ. British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology. Br J Dermatol 2010;162:952-63.
13. Van de Kerkhof PC, De Rooij MJ. Multiple squamous cell carcinomas in a psoriatic patient following high-dose photochemotherapy and cyclosporin treatment: response to long-term acitretin maintenance. Br J Dermatol 1997;136:275-8. (Pubitemid 27062738)
14. Gisondi P, Del GM, Cotena C et al. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial. Br J Dermatol 2008;158:1345-9. (Pubitemid 351692891)
15. Hodulik SG, Zeichner JA. Combination therapy with acitretin for psoriasis. J Dermatolog Treat 2006;17:108-11.
16. Conley J, Nanton J, Dhawan S et al. Novel combination regimens: biologics and acitretin for the treatment of psoriasis - a case series. J Dermatolog Treat 2006;17:86-9.
17. Lowe NJ, Prystowsky JH, Bourget T et al. Acitretin plus UVB therapy for psoriasis. Comparisons with placebo plus UVB and acitretin alone. J Am Acad Dermatol 1991;24:591-4.
18. Saurat JH, Geiger JM, Amblard P et al. Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA and placebo-PUVA in the treatment of severe psoriasis. Dermatologica 1988;177:218-24.
19. Bavinck JN, Tieben LM, Van der Woude FJ et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol 1995;13:1933-8.
20. Chen K, Craig JC, Shumack S. Oral retinoids for the prevention of skin cancers in solid organ transplant recipients: a systematic review of randomized controlled trials. Br J Dermatol 2005;152:518-23. (Pubitemid 40547126)
21. Lebwohl M, Menter A, Koo J et al. Combination therapy to treat moderate to severe psoriasis. J Am Acad Dermatol 2004;50:416-30. (Pubitemid 38316135)
22. Yelverton CB, Yentzer BA, Clark A et al. Home narrowband UV-B phototherapy in combination with low-dose acitretin in patients with moderate to severe psoriasis. Arch Dermatol 2008;144:1224-5.
23. Carlin CS, Callis KP, Krueger GG. Efficacy of acitretin and commercial tanning bed therapy for psoriasis. Arch Dermatol 2003;139:436-42. (Pubitemid 36427607)
24. Ormerod AD, Campalani E, Goodfield MJ. British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology. Br J Dermatol 2010;162:952-63.
25. Dubertret L. Retinoids, methotrexate and cyclosporine. Curr Probl Dermatol 2009;38:79-94.